Does size matter in R&D productivity? If not, what does?

Nature Reviews Drug Discovery

Volumn 12, Issue 12, 2013, Pages 901-902

  Ringel, Michael ^a   Tollman, Peter ^a   Hersch, Greg ^a   Schulze, Ulrik ^a  

^a BOSTON CONSULTING GROUP   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BEHAVIOR; BIOTECHNOLOGY; BUDGET; DRUG INDUSTRY; EXPERIENCE; INFECTION; MEDICAL DECISION MAKING; MOLECULAR WEIGHT; NEUROSCIENCE; NOTE; ORGANIZATION; PATENT; PRIORITY JOURNAL; PRODUCTIVITY; PUBLICATION;

DRUG INDUSTRY; EFFICIENCY; HUMANS; RESEARCH;

EID: 84889593989     PISSN: 14741776     EISSN: 14741784     Source Type: Journal    
DOI: 10.1038/nrd4164     Document Type: Note

References (4)

1. Dimasi, J. A. & Grabowski, H. G. "The cost of biopharmaceutical R&D: Is biotech different?" Managerial Decision Econom. 28, 469-479 (2007
2. Pisano, G. P. Science Business: The Promise, The Reality, and the Future of Biotech 1-256 (Harvard Business School, 2006
3. Morgan, P. et al. Can the flow of medicines be improved? Fundamental pharmacokinetic and pharmacological principles toward improving Phase II survival. Drug Discov. Today 17, 419-424 (2012
4. Morieux, Y. Smart rules: Six ways to get people to solve problems without you. Harv. Bus. Rev. 89, 78-84, 86,136 (2011